Should New HEPZATO Subgroup Data and Delcath’s Targeted Strategy Require Action From DCTH Investors?
Delcath Systems announced that subgroup analyses from its phase 3 FOCUS study of the FDA-approved HEPZATO KIT for unresectable metastatic uveal melanoma were published in the Journal of Cancer ...
Morning Overview on MSN
Doctors surprised by semaglutide’s heart-saving benefits
For years, semaglutide was framed as a powerful tool for diabetes and weight loss. Now cardiologists are confronting a more ...
The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing ...
Dr. Gil Mor discusses sex-specific placental responses and long-term immune alterations from prenatal virus exposure.
UNESCO has called for international bans on smartphones in schools. Many teachers are concerned as well: a survey shows that ...
Scientists created a serum containing extracts from a tropical plant and specialized proteins that support hair follicle ...
Therefore, the ideal candidates for a spinal injection are those with symptoms (sciatica) that are predominantly driven by ...
Since Jennifer and Tom Nguyen arrived in Garland, they have fostered a community for the rapidly growing Vietnamese American ...
Galectin Therapeutics Inc. is rated a Hold due to absence of finalized agreement with FDA, combined with a tight runway. Read ...
Analysis of data from the Sniffies cruising app reveals favorite fetishes, sexual behaviors, and self-identification trends worldwide.
So far this year, at least four states have redrawn their congressional districts with the stated goal of advantaging one party or the other in the 2026 midterms. Several others are exploring similar ...
A new version of the common flu is spreading globally, and health officials are monitoring this evolving strain of influenza A(H3N3) Subclade K, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results